Cystic Fibrosis
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background
J Cyst Fibros. 2022 Dec 19:S1569-1993(22)01425-4. doi: 10.1016/j.jcf.2022.12.005. Online ahead of print.
NO ABSTRACT
PMID:36543707 | DOI:10.1016/j.jcf.2022.12.005
Optic nerve sheath diameter correlates to intracranial pressure in spontaneous CSF leak patients
Int Forum Allergy Rhinol. 2022 Dec 21. doi: 10.1002/alr.23120. Online ahead of print.
NO ABSTRACT
PMID:36541893 | DOI:10.1002/alr.23120
Computationally Efficient Assembly of Pseudomonas aeruginosa Gene Expression Compendia
mSystems. 2022 Dec 21:e0034122. doi: 10.1128/msystems.00341-22. Online ahead of print.
NO ABSTRACT
PMID:36541761 | DOI:10.1128/msystems.00341-22
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
Respir Res. 2022 Dec 20;23(1):363. doi: 10.1186/s12931-022-02301-5.
NO ABSTRACT
PMID:36539829 | DOI:10.1186/s12931-022-02301-5
Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes
Respir Res. 2022 Dec 20;23(1):365. doi: 10.1186/s12931-022-02289-y.
NO ABSTRACT
PMID:36539765 | DOI:10.1186/s12931-022-02289-y
Insights into the molecular basis of c-di-GMP signalling in <em>Pseudomonas aeruginosa</em>
Crit Rev Microbiol. 2022 Dec 20:1-19. doi: 10.1080/1040841X.2022.2154140. Online ahead of print.
NO ABSTRACT
PMID:36539391 | DOI:10.1080/1040841X.2022.2154140
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents
Pediatr Diabetes. 2022 Dec;23(8):1212-1228. doi: 10.1111/pedi.13453.
NO ABSTRACT
PMID:36537525 | DOI:10.1111/pedi.13453
The value of bronchocele attenuation in pulmonary computed tomography in assessment of allergic bronchopulmonary aspergillosis in the background of cystic fibrosis: A cross-sectional study
Ann Med Surg (Lond). 2022 Nov 17;84:104892. doi: 10.1016/j.amsu.2022.104892. eCollection 2022 Dec.
NO ABSTRACT
PMID:36536699 | PMC:PMC9758355 | DOI:10.1016/j.amsu.2022.104892
Exercise and Airway Clearance Techniques in Cystic Fibrosis
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758729. Online ahead of print.
NO ABSTRACT
PMID:36535668 | DOI:10.1055/s-0042-1758729
CFTR Modulators: Current Status and Evolving Knowledge
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758851. Online ahead of print.
NO ABSTRACT
PMID:36535667 | DOI:10.1055/s-0042-1758851
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758730. Online ahead of print.
NO ABSTRACT
PMID:36535666 | DOI:10.1055/s-0042-1758730
Antimicrobial Strategies for Cystic Fibrosis
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758733. Online ahead of print.
NO ABSTRACT
PMID:36535665 | DOI:10.1055/s-0042-1758733
Beyond the Lungs-Emerging Challenges in Adult Cystic Fibrosis Care
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758734. Online ahead of print.
NO ABSTRACT
PMID:36535664 | DOI:10.1055/s-0042-1758734
Respiratory Viruses and Cystic Fibrosis
Semin Respir Crit Care Med. 2022 Dec 19. doi: 10.1055/s-0042-1758728. Online ahead of print.
NO ABSTRACT
PMID:36535663 | DOI:10.1055/s-0042-1758728
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
Contemp Clin Trials Commun. 2022 Dec 6;30:101045. doi: 10.1016/j.conctc.2022.101045. eCollection 2022 Dec.
NO ABSTRACT
PMID:36531900 | PMC:PMC9747573 | DOI:10.1016/j.conctc.2022.101045
The experience of living with and managing cystic fibrosis related diabetes: a qualitative review
J Res Nurs. 2022 Dec;27(8):735-753. doi: 10.1177/17449871221116970. Epub 2022 Nov 4.
NO ABSTRACT
PMID:36530741 | PMC:PMC9755567 | DOI:10.1177/17449871221116970
Commentary: The experience of living with and managing cystic fibrosis related diabetes: a qualitative review
J Res Nurs. 2022 Dec;27(8):754-756. doi: 10.1177/17449871221122836. Epub 2022 Nov 4.
NO ABSTRACT
PMID:36530740 | PMC:PMC9755572 | DOI:10.1177/17449871221122836
Proteomic profiling spotlights the molecular targets and the impact of the natural antivirulent umbelliferone on stress response, virulence factors, and the quorum sensing network of <em>Pseudomonas aeruginosa</em>
Front Cell Infect Microbiol. 2022 Nov 30;12:998540. doi: 10.3389/fcimb.2022.998540. eCollection 2022.
NO ABSTRACT
PMID:36530435 | PMC:PMC9748083 | DOI:10.3389/fcimb.2022.998540
Patient-derived cell models for personalized medicine approaches in cystic fibrosis
J Cyst Fibros. 2022 Dec 16:S1569-1993(22)01419-9. doi: 10.1016/j.jcf.2022.11.007. Online ahead of print.
NO ABSTRACT
PMID:36529661 | DOI:10.1016/j.jcf.2022.11.007
Gene transfection using branched cationic amphiphilic compounds for an aerosol administration in cystic fibrosis context
Int J Pharm. 2022 Dec 15:122491. doi: 10.1016/j.ijpharm.2022.122491. Online ahead of print.
NO ABSTRACT
PMID:36529361 | DOI:10.1016/j.ijpharm.2022.122491